002365 永安药业
已收盘 12-15 15:00:00
资讯
新帖
简况
永安药业：12月5日高管熊盛捷减持股份合计10000股
证券之星 · 12-08
永安药业：12月5日高管熊盛捷减持股份合计10000股
永安药业：截至2025年11月28日股东人数为53,255户
证券之星 · 12-05
永安药业：截至2025年11月28日股东人数为53,255户
永安药业：12月1日高管方锡权、熊盛捷减持股份合计6万股
证券之星 · 12-02
永安药业：12月1日高管方锡权、熊盛捷减持股份合计6万股
永安药业：子公司产品适合抗疲劳人群
证券之星 · 12-02
永安药业：子公司产品适合抗疲劳人群
永安药业：目前暂未生产研发利莫那肽产品
证券之星 · 12-02
永安药业：目前暂未生产研发利莫那肽产品
永安药业（002365）披露参股公司拟被吸收合并暨关联交易公告，11月11日股价上涨2.12%
证券之星 · 11-11
永安药业（002365）披露参股公司拟被吸收合并暨关联交易公告，11月11日股价上涨2.12%
永安药业(002365.SZ)参股公司黄冈日化拟被其全资子公司天安日化吸收合并
智通财经 · 11-11
永安药业(002365.SZ)参股公司黄冈日化拟被其全资子公司天安日化吸收合并
股市必读：永安药业（002365）11月7日董秘有最新回复
证券之星 · 11-10
股市必读：永安药业（002365）11月7日董秘有最新回复
永安药业（002365）披露部分董事、高管减持股份预披露公告，11月7日股价上涨0.12%
中金财经 · 11-08
永安药业（002365）披露部分董事、高管减持股份预披露公告，11月7日股价上涨0.12%
永安药业：截止2025年10月31日股东人数为57,149户
证券之星 · 11-07
永安药业：截止2025年10月31日股东人数为57,149户
永安药业(002365)10月20日股东户数5.97万户，较上期增加2.49%
证券之星 · 11-03
永安药业(002365)10月20日股东户数5.97万户，较上期增加2.49%
永安药业（002365）2025年三季报简析：净利润同比下降58.78%
证券之星 · 10-31
永安药业（002365）2025年三季报简析：净利润同比下降58.78%
图解永安药业三季报：第三季度单季净利润同比增长38.75%
证券之星 · 10-29
图解永安药业三季报：第三季度单季净利润同比增长38.75%
永安药业(002365)10月10日股东户数5.83万户，较上期增加0.57%
证券之星 · 10-27
永安药业(002365)10月10日股东户数5.83万户，较上期增加0.57%
永安药业（002365）披露完成工商变更登记并换发营业执照，10月22日股价下跌0.72%
证券之星 · 10-22
永安药业（002365）披露完成工商变更登记并换发营业执照，10月22日股价下跌0.72%
永安药业（002365）披露选举第七届董事会职工代表董事，10月20日股价下跌1.98%
证券之星 · 10-20
永安药业（002365）披露选举第七届董事会职工代表董事，10月20日股价下跌1.98%
10月14日永安药业发布公告，股东减持222.23万股
证券之星 · 10-14
10月14日永安药业发布公告，股东减持222.23万股
股市必读：永安药业(002365)股东户数5.79万户，较上期减少2.17%
证券之星 · 10-13
股市必读：永安药业(002365)股东户数5.79万户，较上期减少2.17%
永安药业：永安康健将在大力发展合同生产服务业务的同时，持续加大对自有品牌业务的投入
证券日报 · 10-10
永安药业：永安康健将在大力发展合同生产服务业务的同时，持续加大对自有品牌业务的投入
永安药业最新公告：拟2700万元收购控股子公司凌安科技49.20%股权
证券之星 · 09-24
永安药业最新公告：拟2700万元收购控股子公司凌安科技49.20%股权
暂无数据
公司概况
公司名称：
潜江永安药业股份有限公司
所属行业：
医药制造业
上市日期：
2010-03-05
主营业务：
潜江永安药业股份有限公司的主营业务是牛磺酸产品、保健食品、特殊膳食食品（肌酸）的研发、生产和销售。公司的主要产品是牛磺酸产品、保健食品、特殊膳食食品（肌酸）。
发行价格：
31.00
{"stockData":{"symbol":"002365","market":"SZ","secType":"STK","nameCN":"永安药业","latestPrice":15.23,"timestamp":1765782192000,"preClose":15.22,"halted":0,"volume":5299799,"delay":0,"changeRate":0.0007,"floatShares":246000000,"shares":295000000,"eps":0.0863,"marketStatus":"已收盘","change":0.01,"latestTime":"12-15 15:00:00","open":15.16,"high":15.45,"low":15.1,"amount":81089000,"amplitude":0.023,"askPrice":15.23,"askSize":37,"bidPrice":15.22,"bidSize":141,"shortable":0,"etf":0,"ttmEps":0.0863,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1765848600000},"marketStatusCode":5,"adr":0,"adjPreClose":15.22,"symbolType":"stock","openAndCloseTimeList":[[1765762200000,1765769400000],[1765774800000,1765782000000]],"highLimit":16.74,"lowLimit":13.7,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":294682500,"isCdr":false,"pbRate":2.27,"roa":"--","peRate":176.477404,"roe":"1.28%","epsLYR":0.2107,"committee":-0.091639,"marketValue":4488000000,"turnoverRate":0.0216,"status":0,"floatMarketCap":3740000000},"requestUrl":"/m/hq/s/002365/tweets","defaultTab":"tweets","newsList":[{"id":"2589232353","title":"永安药业：12月5日高管熊盛捷减持股份合计10000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2589232353","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589232353?lang=zh_cn&edition=full","pubTime":"2025-12-08 21:02","pubTimestamp":1765198931,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月8日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2025年12月5日公司董秘,高管熊盛捷共减持公司股份1.0万股，占公司总股本为0.0034%。变动期间公司股价上涨0.25%，12月5日当日收盘报15.73元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800032116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","002365","BK0028"],"gpt_icon":0},{"id":"2589174860","title":"永安药业：截至2025年11月28日股东人数为53,255户","url":"https://stock-news.laohu8.com/highlight/detail?id=2589174860","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589174860?lang=zh_cn&edition=full","pubTime":"2025-12-05 16:57","pubTimestamp":1764925034,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)12月05日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！请问公司截至11月30日的股东人数是多少？谢谢永安药业回复：感谢您的关注！截止2025年11月28日，公司股东人数为53,255户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120500025307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","002365","BK0028"],"gpt_icon":0},{"id":"2588053227","title":"永安药业：12月1日高管方锡权、熊盛捷减持股份合计6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588053227","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588053227?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:02","pubTimestamp":1764680544,"startTime":"0","endTime":"0","summary":"证券之星消息，根据12月2日市场公开信息、上市公司公告及交易所披露数据整理，永安药业（002365）最新董监高及相关人员股份变动情况：2025年12月1日公司高管方锡权、董秘,高管熊盛捷共减持公司股份6.0万股，占公司总股本为0.0204%。变动期间公司股价下跌0.24%，12月1日当日收盘报16.29元。永安药业近半年内的董监高及核心技术人员增减持详情如下：永安药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200037308.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002365","BK0086","BK0028"],"gpt_icon":0},{"id":"2588170225","title":"永安药业：子公司产品适合抗疲劳人群","url":"https://stock-news.laohu8.com/highlight/detail?id=2588170225","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588170225?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:02","pubTimestamp":1764637329,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：现在中日关系紧张，士兵们急需牛磺酸饮料抗疲劳，贵公司是否有产品应用于军需食品？是否涉及军工供应饮料？永安药业回复：感谢您的关注！公司主营产品牛磺酸作为食品添加剂，主要应用于食品、饮料行业，子公司永安康健自有品牌相关产品适合抗疲劳的人群，目前公司及子公司均未直接向军方供应相关产品。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","002365","BK0239","BK0028"],"gpt_icon":0},{"id":"2588702299","title":"永安药业：目前暂未生产研发利莫那肽产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2588702299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588702299?lang=zh_cn&edition=full","pubTime":"2025-12-02 09:01","pubTimestamp":1764637277,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)12月01日在投资者关系平台上答复投资者关心的问题。投资者提问：贵公司的利莫那肽产品是否能应用于减肥药？在治疗糖尿病有什么效果吗？有没有取得海内外医学临床试用？永安药业回复：感谢您的关注！公司及子公司主要从事三类业务，一是牛磺酸产品的研发、生产和销售；二是保健食品的研发、生产和销售；三是特殊膳食食品（肌酸）的研发、生产和销售。目前暂未生产研发利莫那肽产品。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200004538.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0086","BK0239"],"gpt_icon":0},{"id":"2582186362","title":"永安药业（002365）披露参股公司拟被吸收合并暨关联交易公告，11月11日股价上涨2.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582186362","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582186362?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:13","pubTimestamp":1762870404,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，永安药业报收于17.84元，较前一交易日上涨2.12%，最新总市值为52.57亿元。近日，潜江永安药业股份有限公司发布公告称，其参股公司黄冈永安日用化工有限公司拟被其全资子公司湖北天安日用化工有限公司吸收合并。合并完成后，黄冈日化将注销，其全部资产、负债及权益由天安日化承继。公司原对黄冈日化的3,000万元投资将相应变更为对天安日化的直接投资，持股比例保持6.5217%不变。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","BK0028","002365"],"gpt_icon":0},{"id":"2582355972","title":"永安药业(002365.SZ)参股公司黄冈日化拟被其全资子公司天安日化吸收合并","url":"https://stock-news.laohu8.com/highlight/detail?id=2582355972","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582355972?lang=zh_cn&edition=full","pubTime":"2025-11-11 15:51","pubTimestamp":1762847505,"startTime":"0","endTime":"0","summary":"智通财经APP讯，永安药业 发布公告，为整合资源、提高效率、降低成本，公司参股公司黄冈永安日用化工有限公司拟被其全资子公司湖北天安日用化工有限公司吸收合并，以天安日化为合并存续方，黄冈日化为被合并方。合并完成后，黄冈日化将予以注销，其全部资产、负债、权益等由天安日化依法承继。公司原对黄冈日化3,000万元投资将转变为公司对天安日化的投资，持股比例将由间接持有天安日化6.5217%的股权转为直接持有天安日化6.5217%的股权。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1367720.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK1240","002365","00028","BK0086","BK0239"],"gpt_icon":0},{"id":"2582181857","title":"股市必读：永安药业（002365）11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582181857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582181857?lang=zh_cn&edition=full","pubTime":"2025-11-10 01:50","pubTimestamp":1762710622,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，永安药业报收于17.29元，上涨0.12%，换手率3.89%，成交量9.54万手，成交额1.66亿元。截止2025年10月31日，公司股东人数为57,149户。来自公司公告汇总：永安药业多名董事及高管拟合计减持不超过235,400股，占公司总股本0.0799%。公司公告汇总关于公司部分董事、高级管理人员减持股份的预披露公告潜江永安药业股份有限公司部分董事、高级管理人员洪仁贵、方锡权、王志华、熊盛捷、李少波合计持有公司股份942,000股，占公司总股本比例0.3197%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000724.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0086","002365","BK0028"],"gpt_icon":0},{"id":"2581580888","title":"永安药业（002365）披露部分董事、高管减持股份预披露公告，11月7日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581580888","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581580888?lang=zh_cn&edition=full","pubTime":"2025-11-08 09:16","pubTimestamp":1762564606,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，潜江永安药业股份有限公司部分董事、高级管理人员洪仁贵、方锡权、王志华、熊盛捷、李少波合计持有公司股份942,000股，占公司总股本比例0.3197%。上述人员计划自公告披露之日起十五个交易日后的三个月内，通过集中竞价交易方式减持不超过235,400股，占公司总股本比例0.0799%。本次减持不会导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251108/31778437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["002365","BK0239","BK0086","BK0028"],"gpt_icon":0},{"id":"2581708350","title":"永安药业：截止2025年10月31日股东人数为57,149户","url":"https://stock-news.laohu8.com/highlight/detail?id=2581708350","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581708350?lang=zh_cn&edition=full","pubTime":"2025-11-07 16:51","pubTimestamp":1762505514,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业(002365)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问至10月31日，股东人数是多少？谢谢！永安药业回复：感谢您的关注！截止2025年10月31日，公司股东人数为57,149户。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700026035.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002365","BK0028","BK0086"],"gpt_icon":0},{"id":"2580298303","title":"永安药业(002365)10月20日股东户数5.97万户，较上期增加2.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580298303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580298303?lang=zh_cn&edition=full","pubTime":"2025-11-03 17:23","pubTimestamp":1762161838,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2025年10月20日公司股东户数为5.97万户，较10月10日增加1451.0户，增幅为2.49%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.44万户。从股价来看，2025年10月10日至2025年10月20日，永安药业区间跌幅为0.0%，在此期间股东户数增加1451.0户，增幅为2.49%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300023575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0239","BK0028","BK0086"],"gpt_icon":0},{"id":"2579101504","title":"永安药业（002365）2025年三季报简析：净利润同比下降58.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579101504","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579101504?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:42","pubTimestamp":1761864150,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期永安药业发布2025年三季报。根据财报显示，永安药业净利润同比下降58.78%。截至本报告期末，公司营业总收入5.77亿元，同比下降6.72%，归母净利润2549.63万元，同比下降58.78%。按单季度数据看，第三季度营业总收入2.1亿元，同比上升8.75%，第三季度归母净利润1300.05万元，同比上升38.75%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365"],"gpt_icon":0},{"id":"2579297974","title":"图解永安药业三季报：第三季度单季净利润同比增长38.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579297974","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579297974?lang=zh_cn&edition=full","pubTime":"2025-10-29 19:02","pubTimestamp":1761735749,"startTime":"0","endTime":"0","summary":"证券之星消息，永安药业2025年三季报显示，前三季度公司主营收入5.77亿元，同比下降6.72%；归母净利润2549.63万元，同比下降58.78%；扣非净利润518.44万元，同比下降86.17%；其中2025年第三季度，公司单季度主营收入2.1亿元，同比上升8.75%；单季度归母净利润1300.05万元，同比上升38.75%；单季度扣非净利润289.91万元，同比上升91.82%；负债率10.93%，投资收益2532.25万元，财务费用-123.0万元，毛利率17.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365"],"gpt_icon":0},{"id":"2578616658","title":"永安药业(002365)10月10日股东户数5.83万户，较上期增加0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578616658","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578616658?lang=zh_cn&edition=full","pubTime":"2025-10-27 17:11","pubTimestamp":1761556310,"startTime":"0","endTime":"0","summary":"证券之星消息，近日永安药业披露，截至2025年10月10日公司股东户数为5.83万户，较9月30日增加333.0户，增幅为0.57%。在化学制药行业个股中，永安药业股东户数高于行业平均水平，截至10月10日，化学制药行业平均股东户数为3.26万户。从股价来看，2025年9月30日至2025年10月10日，永安药业区间跌幅为1.44%，在此期间股东户数增加333.0户，增幅为0.57%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700023258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","002365","BK0239","BK0028"],"gpt_icon":0},{"id":"2577393970","title":"永安药业（002365）披露完成工商变更登记并换发营业执照，10月22日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577393970","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577393970?lang=zh_cn&edition=full","pubTime":"2025-10-22 22:11","pubTimestamp":1761142277,"startTime":"0","endTime":"0","summary":"截至2025年10月22日收盘，永安药业报收于17.82元，较前一交易日下跌0.72%，最新总市值为52.51亿元。该股当日开盘17.88元，最高18.14元，最低17.67元，成交额达2.22亿元，换手率为5.06%。公司近日发布公告称，潜江永安药业股份有限公司于2025年9月24日及10月14日召开董事会及临时股东会，审议通过变更经营范围、增加董事会成员人数并修订《公司章程》的议案。公司已完成工商变更登记及《公司章程》备案手续，并取得湖北省市场监督管理局换发的营业执照。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102200037477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002365","BK0028","BK0086","BK0239"],"gpt_icon":0},{"id":"2576129868","title":"永安药业（002365）披露选举第七届董事会职工代表董事，10月20日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576129868","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576129868?lang=zh_cn&edition=full","pubTime":"2025-10-20 22:14","pubTimestamp":1760969660,"startTime":"0","endTime":"0","summary":"截至2025年10月20日收盘，永安药业报收于17.82元，较前一交易日下跌1.98%，最新总市值为52.51亿元。近日，永安药业发布关于选举第七届董事会职工代表董事的公告。公告称，潜江永安药业股份有限公司于2025年10月17日召开职工代表大会，选举夏沙先生为公司第七届董事会职工代表董事。夏沙先生将与公司2023年年度股东大会选举产生的六名非职工代表董事共同组成第七届董事会，任期自职工代表大会通过之日起至第七届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102000032238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","002365","BK0028","BK0239"],"gpt_icon":0},{"id":"2575629027","title":"10月14日永安药业发布公告，股东减持222.23万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575629027","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575629027?lang=zh_cn&edition=full","pubTime":"2025-10-14 20:15","pubTimestamp":1760444103,"startTime":"0","endTime":"0","summary":"证券之星消息，10月14日永安药业发布公告《永安药业:关于公司控股股东、实际控制人之一致行动人减持计划实施完成的公告》，其股东黄冈永安药业有限公司于2025年9月5日至2025年10月13日间合计减持222.23万股，占公司目前总股本的0.7541%，变动期间该股股价下跌1.84%，截止10月13日收盘报18.63元。股东增减持详情见下表：根据永安药业2025年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101400061375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","002365","BK0028"],"gpt_icon":0},{"id":"2575411341","title":"股市必读：永安药业(002365)股东户数5.79万户，较上期减少2.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575411341","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575411341?lang=zh_cn&edition=full","pubTime":"2025-10-13 01:42","pubTimestamp":1760290933,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘，永安药业报收于17.82元，下跌0.06%，换手率6.56%，成交量16.1万手，成交额2.89亿元。当日关注点来自交易信息汇总：10月10日主力资金净流出3125.12万元，显示主力短期内可能看空。股本股东变化股东户数变动近日永安药业披露，截至2025年9月30日公司股东户数为5.79万户，较8月29日减少1287.0户，减幅为2.17%。户均持股数量由上期的4977.0股增加至5087.0股，户均持股市值为9.2万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300000618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002365","BK0239","BK0086"],"gpt_icon":0},{"id":"2574178751","title":"永安药业：永安康健将在大力发展合同生产服务业务的同时，持续加大对自有品牌业务的投入","url":"https://stock-news.laohu8.com/highlight/detail?id=2574178751","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574178751?lang=zh_cn&edition=full","pubTime":"2025-10-10 18:32","pubTimestamp":1760092320,"startTime":"0","endTime":"0","summary":"证券日报网讯永安药业10月10日在互动平台回答投资者提问时表示，公司子公司永安康健自成立以来一直深耕于大健康产业，已构建“合同生产服务”与“自主品牌运营”双轨发展模式。后续，永安康健将在大力发展合同生产服务业务的同时，持续加大对自有品牌业务的投入，加强产品研发与市场推广，进一步提升该业务的市场认可度与持续发展能力。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-10/doc-inftmhci1282345.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-10/doc-inftmhci1282345.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","BK0239","002365","BK0086"],"gpt_icon":0},{"id":"2569595772","title":"永安药业最新公告：拟2700万元收购控股子公司凌安科技49.20%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2569595772","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569595772?lang=zh_cn&edition=full","pubTime":"2025-09-24 17:28","pubTimestamp":1758706082,"startTime":"0","endTime":"0","summary":"永安药业(002365.SZ)公告称，公司拟使用自有资金2700万元收购凌安科技少数股东张勇、夏昌培、代亮合计持有的凌安科技49.20%股权。收购完成后，公司将持有凌安科技100%股权。本次交易不构成关联交易，不构成重大资产重组。凌安科技为永安药业重要子公司，主要从事一水肌酸业务。此次收购旨在强化公司对凌安科技的管控，降低管理成本与控制风险，提升运营决策管理效率，加速其在一水肌酸领域的业务拓展与市场布局。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092400030382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0086","BK0239","002365"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1765814182983,"stockEarnings":[{"period":"1week","weight":-0.0324},{"period":"1month","weight":-0.1357},{"period":"3month","weight":-0.1669},{"period":"6month","weight":-0.3952},{"period":"1year","weight":0.6913},{"period":"ytd","weight":0.9113}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"潜江永安药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"53255人(较上一季度减少1.37%)","perCapita":"4611股","listingDate":"2010-03-05","address":"湖北省潜江市经济开发区广泽大道2号","registeredCapital":"29468万元","survey":" 潜江永安药业股份有限公司的主营业务是牛磺酸产品、保健食品、特殊膳食食品（肌酸）的研发、生产和销售。公司的主要产品是牛磺酸产品、保健食品、特殊膳食食品（肌酸）。","listedPrice":31},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"永安药业,002365,永安药业股票,永安药业股票老虎,永安药业股票老虎国际,永安药业行情,永安药业股票行情,永安药业股价,永安药业股市,永安药业股票价格,永安药业股票交易,永安药业股票购买,永安药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"永安药业(002365)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供永安药业(002365)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}